BioSpace News Archive

Radionetics Oncology announced the appointment of Umesh Gangadharmath, Ph.D. as Senior Vice President, Technical Operations.

Pressure BioSciences, Inc. highlighted two significant presentations given at the Conference of Food Engineering 2022 by a distinguished research team at the College of Food, Agricultural, and Environmental Sciences at The Ohio State University and co-authored by members of PBI’s R&D and Engineering teams.

Critical Path Institute named Daniel M. Jorgensen, M.D., MPH, MBA, its Chief Executive Officer.

Neogen Corporation (NASDAQ: NEOG) announced today that Steve Quinlan , the company’s Chief Financial Officer, has announced his intent to retire effective May 31, 2023, at the conclusion of the company’s fiscal year.

The global Research Antibodies market size is expected to surpass around US$ 16.5 billion by 2030, according to a new report by Vision Research Reports.

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers announced that the U.S. Food and Drug Administration has granted Fast Track designation for AL102 for the treatment of progressing desmoid tumors.

Kaléo, a fully integrated pharmaceutical company dedicated to inventing, manufacturing, and commercializing life-transforming products, announced the appointment of its new Chief Business Officer.

atai Life Sciences N.V. announced today its Phase 1 study has received regulatory and ethics approvals required from Medsafe and HDEC, respectively, to initiate participant enrollment.

Alafair Biosciences, a leader in non-collagenous soft tissue protection, announced enrollment of the tenth patient in a prospective, randomized, and blinded clinical study designed to assess the VersaWrap® device in a controlled injury model.

Achieve Life Sciences, Inc. today announced that target enrollment of 750 subjects has been reached in the Phase 3 ORCA-3 trial.